These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 15028313

  • 1. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial.
    Degiuli M, Sasako M, Calgaro M, Garino M, Rebecchi F, Mineccia M, Scaglione D, Andreone D, Ponti A, Calvo F, Italian Gastric Cancer Study Group.
    Eur J Surg Oncol; 2004 Apr; 30(3):303-8. PubMed ID: 15028313
    [Abstract] [Full Text] [Related]

  • 2. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
    Ikeguchi M, Oka S, Gomyo Y, Tsujitani S, Maeta M, Kaibara N.
    Anticancer Res; 2000 Apr; 20(2B):1285-9. PubMed ID: 10810436
    [Abstract] [Full Text] [Related]

  • 3. [Surgical outcome of 801 patients with localized gastric cancer treated with d2 lymphadenectomy].
    Ruiz E, Sanchez J, Celis J, Payet E, Berrospi F, Chavez I, Young F.
    Rev Gastroenterol Peru; 2009 Apr; 29(2):124-31. PubMed ID: 19609327
    [Abstract] [Full Text] [Related]

  • 4. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.
    Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P.
    Br J Cancer; 1999 Mar; 79(9-10):1522-30. PubMed ID: 10188901
    [Abstract] [Full Text] [Related]

  • 5. [D3 versus D2 dissection in stomach carcinoma. A case-control study of postoperative morbidity, survival and early oncologic outcome].
    Bittorf BR, Günther F, Merkel S, Horbach T, Hohenberger W, Günther K.
    Chirurg; 2002 Apr; 73(4):336-47. PubMed ID: 12063918
    [Abstract] [Full Text] [Related]

  • 6. [The role of superextended lymphadenectomy (D4) in gastric cancer].
    Pugliese R, Maggioni D, Sansonna F, Scandroglio I, Di Lernia S, Boniardi M, Bramerio MA.
    Minerva Chir; 2004 Aug; 59(4):325-35. PubMed ID: 15278027
    [Abstract] [Full Text] [Related]

  • 7. Resection for gastric cancer in the community.
    van de Velde CJ.
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
    [Abstract] [Full Text] [Related]

  • 8. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.
    Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, Welvaart K, van Krieken JH, Meijer S, Plukker JT, van Elk PJ, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Sasako M.
    J Clin Oncol; 2004 Jun 01; 22(11):2069-77. PubMed ID: 15082726
    [Abstract] [Full Text] [Related]

  • 9. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study.
    Roukos DH, Lorenz M, Encke A.
    Surgery; 1998 May 01; 123(5):573-8. PubMed ID: 9591011
    [Abstract] [Full Text] [Related]

  • 10. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.
    Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ.
    Lancet Oncol; 2010 May 01; 11(5):439-49. PubMed ID: 20409751
    [Abstract] [Full Text] [Related]

  • 11. [Comparative study of D1 and D2 ganglionic dissection in advanced gastric cancer at Rebagliati Hospital].
    Cornejo C, Portanova M.
    Rev Gastroenterol Peru; 2006 May 01; 26(4):351-6. PubMed ID: 17211484
    [Abstract] [Full Text] [Related]

  • 12. Long-term survival is improved by an extended lymph node dissection in potentially curable gastric cancer.
    Reis E, Kama NA, Doganay M, Atli M, Dolapci M.
    Hepatogastroenterology; 2002 May 01; 49(46):1167-71. PubMed ID: 12143228
    [Abstract] [Full Text] [Related]

  • 13. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
    Ramacciato G, Aurello P, D'Angelo F, Cicchini C, Sternberg CN.
    Hepatogastroenterology; 2000 May 01; 47(35):1470-4. PubMed ID: 11100379
    [Abstract] [Full Text] [Related]

  • 14. Extended lymphadenectomy in gastric cancer: when, for whom and why.
    Roukos DH.
    Ann R Coll Surg Engl; 1998 Jan 01; 80(1):16-24. PubMed ID: 9579122
    [Abstract] [Full Text] [Related]

  • 15. R2 compared with R1 resection for gastric cancer: morbidity and mortality in a prospective, randomised trial.
    Bonenkamp JJ, van de Velde CJ, Sasako M, Hermans J.
    Eur J Surg; 1992 Aug 01; 158(8):413-8. PubMed ID: 1356480
    [Abstract] [Full Text] [Related]

  • 16. [Extensive lymph node dissection in stomach cancer? Initial results of the Dutch Stomach Cancer Study].
    Bonenkamp JJ, Songun I, Hermans J, van de Velde CJ.
    Ned Tijdschr Geneeskd; 1996 May 04; 140(18):964-7. PubMed ID: 8692311
    [Abstract] [Full Text] [Related]

  • 17. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial.
    Kulig J, Popiela T, Kolodziejczyk P, Sierzega M, Szczepanik A, Polish Gastric Cancer Study Group.
    Am J Surg; 2007 Jan 04; 193(1):10-5. PubMed ID: 17188080
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of radical D2-lymphadenectomy and splenectomy in surgically treated gastric cancer patients.
    Schmid A, Thybusch A, Kremer B, Henne-Bruns D.
    Hepatogastroenterology; 2000 Jan 04; 47(32):579-85. PubMed ID: 10791243
    [Abstract] [Full Text] [Related]

  • 19. Laparoscopic gastrectomy for treatment of advanced gastric cancer: preliminary experience on 38 cases.
    Allieta R, Nardi M, Brachet-Contul R, Millo P, Fabozzi M, Cornaglia S, Parini U.
    Minerva Chir; 2009 Oct 04; 64(5):445-56. PubMed ID: 19859035
    [Abstract] [Full Text] [Related]

  • 20. Extended lymph-node dissection for gastric cancer.
    Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ, Welvaart K, Songun I, Meyer S, Plukker JT, Van Elk P, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Dutch Gastric Cancer Group.
    N Engl J Med; 1999 Mar 25; 340(12):908-14. PubMed ID: 10089184
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.